Transaction DateRecipientSharesTypePriceValue
25th August 2020Bernie B Iii Berry670Exercise of derivative$30.97$20,749.90
25th June 2020Mark C Throdahl13,389Open or private sale$42.88$574,120.32
25th June 2020Fred Hite10,000Grant/award etc.$0.00
25th June 2020Mark C Throdahl30,000Grant/award etc.$44.08$1,322,400.00
19th June 2020David R Pelizzon1,340Exercise of derivative$30.97$41,499.80
19th June 2020Capital Llc Squadron1,340Exercise of derivative$30.97$41,499.80
17th June 2020David R Pelizzon21,142Grant/award etc.$0.00
3rd June 2020Kevin Unger1,400Grant/award etc.$0.00
3rd June 2020David R Pelizzon1,400Grant/award etc.$0.00
3rd June 2020Bernie B Iii Berry1,400Grant/award etc.$0.00
Ortho Pediatrics
Ortho Pediatrics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


OrthoPediatrics Corp. is a medical device company. Its products includes PediLoc, PediPlates, Cannulated Screws and PediFlexTM nail.


Ticker: KIDS
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1425450
Employees: 94
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $113 M (59%)
Inventory, Net: $49 M (28%)
Assets, Current: $180 M (40%)
Property, Plant and Equipment, Net: $24 M (13%)
Assets: $328 M (80%)
Long-term Debt, Current Maturities: $128 Th (3%)
Accounts Payable, Current: $6 M (-7%)
Liabilities, Current: $25 M (81%)
Long-term Debt, Excluding Current Maturities: $21 M (-19%)
Other Liabilities, Noncurrent: $120 Th (90%)
Liabilities: $86 M (116%)
Common Stock, Value, Issued: $5 Th (25%)
Common Stock, Shares, Issued: $20 M (16%)
Retained Earnings (Accumulated Deficit): $143 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $161 Th (5266%)
Stockholders' Equity (Parent): $242 M (0%)
Liabilities and Equity: $328 M (80%)
Revenue: $14 M (0%)
Cost of Revenue: $4 M (-53%)
Gross Margin: $10 M (-54%)
Research and Development: $881 Th (-58%)
Sales and Marketing: $6 M (-57%)
General and Administrative Expenses: $11 M (-42%)
Operating Income/Loss: $7 M (-39%)
Other Income, net: $2 M (-15%)